Abstract:Abstract Background Lung cancer in very young adults in China aged <30 is on the rise and the clinicopathological characteristics of this unique population are incomplete and are yet to be elucidated. Our study aims to explore the characteristics, trends and distinctive features of lung cancer this age group to provide more information that can aid in developing optimal treatment regimens and improve prognosis for this exclusive age group. Method A retrospective review of 141 lung cancer patients admitted at our hospital from August 2011 to October 2021 was performed. The focused age group in our study was 18-30 years old. The data collected included demographics, tumor pathology, gene mutations, and treatment. Overall survival and prognosis were systematically analyzed. Results From a total of 141 of young lung cancer patients, 139 were included in final analysis. The gender distribution in our series favored female(65.5%), and only 7.2% of the study cohort had a history of smoking. Adenocarcinoma was the most common histological type in our study, presenting 93.5% of all patients. The most common stages at diagnosis was stage I(61.2%) and stage IV(30.2%). Genetic testing was performed in only 24.5% (34/139) of the patients. From the 23/34 patients in our study who tested positive for a genetic mutation, 19 (82.3%) were stage IV. The most common gene mutation was Anaplastic Lymphoma kinase(ALK) rearrangement observed in 13/23 (56.5%) gene mutation positive patients. Among stage IV NSCLC, OS was longer in patients who received targeted therapy, compared to the patients not receiving target therapy: 88 months vs 24 months (95% CI: 0.15-1.0, p=0.0282). Conclusion Lung cancer in the young adult population has particular characteristics (Common in female, non-smoker and adenocarcinoma patients). Higher stages of disease were observed in those with a gene mutation (notably ALK rearrangement). Although the sample size was small, the current data suggests a higher mutation rate in the younger population. These findings have fundamental implications for practice and we propose that all patients under 30 diagnosed with lung cancer should undergo genetic testing so they can receive personalized treatment and therefore achieve better outcomes.

Young Adults with Colon Cancer: Clinical Features and Surgical Outcomes

The clinical features of breast cancer in young patients

Clinicopathologic Characteristics and Prognosis for Young Gastric Adenocarcinoma Patients after Curative Resection

Pathological Features and Survival Outcomes of Young Patients with Operable Colon Cancer: Are They Homogeneous?

Young Patients With Colorectal Cancer Have Higher Early Mortality but Better Long-Term Survival

Demographics, Risk Factors and Survival Analysis of Lung Cancer in Young Adults (&lt;30 Years) in China-A Retrospective Cohort Study

Young Patients (≤35years Old) with Colorectal Cancer Have Worse Outcomes Due to More Advanced Disease

Changing Trends in Gastric and Colorectal Cancer among Surgical Patients over 85 Years Old: A Multicenter Retrospective Study, 2001–2021

Better long-term survival in young patients with non-metastatic colorectal cancer after surgery, an analysis of 69,835 patients in SEER database.

Clinicopathological characteristic and prognosis analysis of young patients with colorectal cancer

Clinical Characteristics and Prognosis of Young Patients with Colorectal Cancer in Eastern China

Young-Onset Rectal Cancer: Presentation, Pattern of Care and Long-term Oncologic Outcomes Compared to a Matched Older-Onset Cohort

Surgical outcomes for non‐small cell lung cancer in younger adults: A population‐based study

Postoperative Chemotherapy Use and Survival in Non-High-risk Young and High-Risk Old-Aged Patients with Stage II Colon Cancer

Are more aggressive treatments associated with better prognosis among patients with young-onset rectal cancer?

Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger

Clinicopathological Features And Prognostic Factors Of Young Patients With Surgically Treated Liver Cancer

Early-Onset Colorectal Cancer in Patients under 50 Years of Age: Demographics, Disease Characteristics, and Survival

Do Young Patients with Colorectal Cancer Have a Poorer Prognosis Than Old Patients?

Clinicopathological features of colorectal cancer patients under 30 years of age

Stage IV Non-Small Cell Lung Cancer among Young Individuals: Incidence, Presentations, and Survival Outcomes of Conventional Therapies